Form 4 for EXOZ EXOZYMES INC.
Accepted 2026-04-08 19:22:21 ET · period of report 2026-04-01 · accession 0001493152-26-015761 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-04-08 19:22 | 2026-04-01 | EXOZ | Perriman Damien Alan | Chief Commercial Off | A - Grant | $0.00 | +62.8K | 62.8K | New | $0 |
| D | 2026-04-08 19:22 | 2026-04-01 | EXOZ | Perriman Damien Alan | Chief Commercial Off | A - Grant | $0.00 | +146.4K | 146.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Restricted Stock Grant for Common Stock | 2026-04-01 | A | A | 62,759 | $0.00 | 62,759 | D | — | — | (F1) The shares underlying the grant of the restricted stock vest at a rate of 3,923 shares per quarter, with 15,689 shares vesting immediately. The final vesting installment consists of 3,917 shares on April 1, 2029. The grant and each vesting is pursuant to Rule 16b-3 of Section 16 of the Securities and Exchange Act of 1934, as amended. |
| 2 | Derivative | Stock Option for Common Stock | 2026-04-01 | A | A | 146,437 | $0.00 | 146,437 | D | $9.49 · 2026-04-01 to 2033-04-12 | 146,437 Common Stock | (F2) The shares underlying the stock option grant vest at a rate of 3,050 shares per month, with 36,609 shares vesting immediately. The final vesting installment consists of 3,078 shares on April 1, 2029. The grant and each exercise of the option is pursuant to Rule 16b-3 of Section 16 of the Securities and Exchange Act of 1934, as amended. |